 Cue Biopharma, Inc. NASDAQ:CUE Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Dan Passeri - Chief Executive Officer Anish Suri - President Chief Scientific Officer Ken Pienta - Acting Chief Medical Officer Matteo Levisetti - Senior Vice President of Clinical Development Kerri Millar - Chief Financial Officer Conference Call Participants Reni Benjamin - JMP Securities Operator Greetings, and welcome to the Cue Biopharma Update Call. A question-and-answer session will follow the presentation. 